Group 1 - The company has approved the use of idle raised funds not exceeding 90 million yuan to temporarily supplement working capital, with a usage period of no more than 12 months from the board's approval date [2][6][7] - The company has established a special account for raised funds, which will only be used for temporarily supplementing working capital, and has signed a tripartite supervision agreement with the sponsor and the bank [3][5][6] - The company raised a total of 1,075,950,160 yuan from its initial public offering, with a net amount of 978,057,381.28 yuan after deducting issuance costs [2][4] Group 2 - The company will have 15,639,463 shares listed for circulation on September 15, 2025, following the issuance of shares to specific investors [15][16] - The total share capital of the company will increase to 277,885,415 shares after the issuance, and further to 333,462,498 shares after a capital reserve transfer [17][18] - The independent financial advisor has confirmed that the shareholders of the restricted shares have complied with their commitments, and the listing of these shares meets regulatory requirements [19][20] Group 3 - The company will participate in a collective performance briefing for the medical device industry on September 17, 2025, to communicate its half-year results and address investor questions [33][34] - Investors can submit questions for the briefing from September 10 to September 16, 2025, and the company will respond to commonly asked questions during the event [35][36]

Core Viewpoint - The company has established a specialized management system for the storage and use of raised funds to enhance the efficiency of fund utilization and protect investors' legal rights [1][2]. Fund Storage - Raised funds must be stored in a dedicated account approved by the board of directors, and cannot be used for non-raising purposes [7][8]. - A tripartite supervision agreement must be signed with the sponsor and the commercial bank within one month of the funds being received [8][3]. Fund Usage - The company must adhere to strict approval procedures for fund usage, ensuring that all expenditures are documented and approved by relevant authorities [9][10]. - Funds should primarily be used for the main business operations, and any changes in usage must be approved by the board and disclosed [10][20]. - If the actual use of funds deviates from the planned usage due to unforeseen circumstances, the company must report to the board and disclose the reasons [9][10]. Management and Supervision - The company is required to disclose the actual usage of raised funds accurately and completely, with a special report submitted to the board every six months [25][15]. - Independent directors and the audit committee must continuously monitor the management and usage of raised funds [26][27]. Changes in Fund Usage - Any changes to the investment projects funded by raised funds must be approved by the board and shareholders, with independent opinions required [20][22]. - If there are surplus funds after project completion, they can only be used for other projects after board approval [18][19].

Core Points - The document outlines the fundraising management measures for Zhuhai Hengji Daxin International Chemical Storage Co., Ltd, aiming to standardize the company's operations and protect the rights of investors [2][3] - It emphasizes the importance of proper use and management of raised funds, ensuring they align with the company's business objectives and legal regulations [6][7] Fundraising Overview - The term "raised funds" refers to capital obtained through stock issuance or other equity-like securities for specific purposes, excluding funds raised for equity incentive plans [2] - The company must establish a special account for raised funds, ensuring that these funds are not mixed with other financial resources [3] Fund Management and Usage - The board of directors is responsible for thoroughly evaluating the feasibility of investment projects funded by raised capital, ensuring they have good market prospects and profitability [3][6] - The company must disclose the actual usage of raised funds accurately and completely, and any significant deviations from the planned investment must be reported promptly [7][8] Fund Usage Restrictions - Raised funds should primarily be used for the company's main business activities and must not be used for high-risk investments or financial assistance to others [6][9] - Any changes in the use of raised funds require board approval and must be disclosed to shareholders [9][10] Monitoring and Reporting - The company is required to maintain detailed records of the usage of raised funds and undergo regular audits to ensure compliance with regulations [14][15] - Independent financial advisors or sponsors must conduct periodic checks on the management and usage of raised funds, reporting any irregularities to the relevant authorities [15][16]

Core Viewpoint - The company has announced the establishment of a special account for raised funds and signed a tripartite supervision agreement for the management of these funds, aimed at ensuring compliance with regulations and protecting investor interests [1][5]. Fundraising Overview - The company approved the temporary use of up to 90 million yuan of idle raised funds to supplement working capital, with a usage period not exceeding 12 months from the board's approval date [2]. - The company raised a total of 1,075,950,160 yuan from its initial public offering (IPO) by issuing 51,333,500 shares at a price of 20.96 yuan per share, with a net amount of 978,892,778.72 yuan after deducting issuance costs [2][3]. - Additionally, the company raised 203,920,127.60 yuan through a share issuance for asset acquisition, issuing 13,032,886 shares at a price of 16.42 yuan per share, after deducting related issuance costs [3][4]. Special Account and Supervision Agreement - A special account has been opened at Shanghai Pudong Development Bank for the storage of temporarily supplemented working capital, with a tripartite supervision agreement signed between the company, the bank, and the financial advisor, Dongfang Securities [5][6]. - The agreement stipulates that the funds in the special account are exclusively for temporary working capital and cannot be used for other purposes [6][7]. - The financial advisor is responsible for supervising the use of the raised funds and must conduct regular checks and provide monthly account statements to the company [6][8]. Compliance and Legal Framework - The agreement is governed by relevant laws and regulations, including the Company Law and the Securities Law of the People's Republic of China, ensuring that all parties adhere to legal requirements [8][9]. - Any disputes arising from the agreement will be resolved through negotiation or arbitration in Shanghai, with the arbitration ruling being final and binding [9].

Core Points - The document outlines the management and usage of funds raised by Shandong Hualu Hengsheng Chemical Co., Ltd, emphasizing compliance with relevant laws and regulations [1][2][3] - The company must ensure that raised funds are used specifically for designated purposes, primarily related to its main business operations, and must not engage in financial investments [1][2][3] - The document establishes internal control systems for fund management, including approval processes and risk control measures [2][3][4] Fund Storage - The company is required to store raised funds in a centralized manner to facilitate supervision, using dedicated accounts [9][10] - A tripartite supervision agreement must be established with the underwriter or independent financial advisor and the commercial bank where the funds are stored [11][12] - The company must ensure that funds are not used for purposes outside the approved investment projects [13][14] Fund Usage - The company must strictly adhere to the usage plan outlined in the issuance documents and cannot change the purpose of the funds without proper approval [14][15] - In cases where the investment project cannot be completed on time, the company must report to the exchange and disclose reasons for delays [16][17] - Any changes in the investment project must be approved by the board and disclosed to stakeholders [18][19] Fund Management and Supervision - The company is required to provide accurate and complete disclosures regarding the actual usage of raised funds [33][34] - The underwriter must conduct ongoing supervision and report any irregularities to regulatory authorities [35][36] - The company’s accounting department must maintain detailed records of fund expenditures and project investments [37]

Fundraising Overview - The company issued 30 million convertible bonds at a price of 100 RMB each, raising a total of 3 billion RMB, with a net amount of 2.980054 billion RMB after deducting fees [1][2] - The funds raised are subject to verification by KPMG, which issued a report confirming the amount [1] Fund Usage Changes - The company has terminated the original fundraising projects and redirected the funds towards new projects, including the construction of an intelligent infusion production line and upgrades to existing production lines [1][2] - The company plans to use up to 1.25 billion RMB of idle funds to temporarily supplement working capital, with a repayment period not exceeding 12 months [2] Fund Management and Supervision - The company has established special accounts for the management of the raised funds and signed regulatory agreements with banks and underwriters to ensure proper oversight [2][4] - The supervisory agreements involve multiple parties, including the company, its subsidiaries, and the underwriting institution, ensuring compliance with regulations [4][5] Account Opening and Balance - As of September 4, 2025, the company has opened several special accounts with Bank of China for the management of the raised funds [3][4]

Core Viewpoint - The company, Zhejiang Tianzhen Technology Co., Ltd., is undergoing significant changes in its fundraising projects and operational strategies due to external trade pressures and internal performance challenges [1][3][8]. Summary by Relevant Sections Company Operations and Fundraising Projects - The company has extended the construction period of its fundraising project in the U.S. to June 30, 2027, changing the project from an annual production capacity of 3 million square meters to 2 million square meters of new inorganic composite flooring [1][2][4]. - The U.S. project is now managed by a new entity, Boson New Materials Company, located in Georgia, with construction expected to start in December 2024 and production to begin in July 2025 [1][2][4]. Performance and Challenges - The company has faced significant challenges due to U.S. customs imposing strict import restrictions, which have severely impacted export orders and overall business performance [2][3][8]. - As of 2024, the company is projected to incur losses, prompting it to enhance research and development efforts and explore new product lines to stabilize its operations [3][8]. Compliance and Regulatory Actions - The company has been reminded to continuously monitor factors leading to performance fluctuations and to fulfill its information disclosure obligations [2][3][10]. - Due to the improper use of idle fundraising capital, the company and its executives received warnings from regulatory bodies, necessitating a comprehensive review and improvement of internal controls related to fundraising management [9][10].

Core Viewpoint - The company plans to use its own funds to pay for part of the fundraising project expenses and will subsequently replace these with equivalent amounts from the raised funds, ensuring compliance with regulatory requirements and maintaining the integrity of the fundraising process [1][5]. Fundraising Basic Situation - The company issued 4.946 million convertible bonds at a face value of 100 RMB each, raising a total of 494.60 million RMB, which is stored in a designated account [2]. - After deducting issuance costs, the net amount available for investment is 485.61 million RMB [2]. Fundraising Investment Project Situation - The funds raised will be allocated to the following projects: - Digital Banking Service Platform Construction Project: 339.22 million RMB allocated, with 39.25 million RMB (11.57%) utilized as of June 30, 2025 - Supplementing Working Capital: 146.39 million RMB fully utilized [2]. Reasons for Using Own Funds - The company needs to cover personnel costs such as salaries and social security, which must be paid through a basic deposit account as per regulations. Using the fundraising account directly for these payments would not comply with the requirements [2][3]. Impact on the Company - The use of self-funds for project payments and subsequent replacement with raised funds will not affect the normal implementation of the fundraising project and does not constitute a change in the direction of the raised funds or harm shareholder interests [4][5]. Review Procedures and Opinions - The board of directors approved the proposal to use self-funds for project payments, and the audit committee confirmed that the necessary decision-making procedures were followed, ensuring no adverse effects on the fundraising project [4][5]. Sponsor's Verification Opinion - The sponsor has verified that the company's actions comply with relevant regulations and will not impact the fundraising project's investment plan or shareholder interests [5].

Core Viewpoint - The document outlines the fundraising management measures of Guangdong Star Development Co., Ltd., aiming to standardize the management of raised funds, improve their utilization efficiency, and protect investors' interests [2][3]. Group 1: General Principles - The company establishes these measures based on various laws and regulations, including the Company Law and Securities Law of the People's Republic of China [2]. - The term "raised funds" includes funds from initial public offerings, follow-on offerings, and convertible bonds, as well as private placements for specific purposes [2]. Group 2: Fund Management and Oversight - The board of directors must establish internal control systems for the storage, use, and management of raised funds, detailing storage, usage, changes, supervision, and accountability [3]. - Directors and senior management are required to ensure the proper use of raised funds and prevent unauthorized changes in their usage [3]. - Major shareholders and actual controllers are prohibited from misappropriating or occupying the company's raised funds [3]. Group 3: Fund Storage - The company must set up dedicated accounts at reputable banks for storing raised funds, with the number of accounts not exceeding the number of investment projects [4]. - A tripartite supervision agreement must be signed with the underwriter and the bank within one month of the funds being in place [4]. Group 4: Fund Usage - Raised funds should primarily be used for the company's main business, and financial investments or loans are strictly prohibited [6][7]. - The company must disclose the actual usage of raised funds accurately and completely, with regular reports to the board [7][8]. Group 5: Changes in Fund Usage - Any changes in the use of raised funds must be approved by the board and disclosed to the Shenzhen Stock Exchange [13][14]. - If a project is terminated or funds remain after project completion, the company must follow specific procedures to reallocate those funds [16][17]. Group 6: Supervision and Accountability - The accounting department must maintain detailed records of fund usage, and internal audits should occur quarterly [36]. - Any violations in fund usage leading to losses will result in legal accountability for responsible personnel [40].

Core Viewpoint - The regulatory warning highlights significant compliance issues within Shenhuo Co., Ltd, indicating serious internal control deficiencies and potential risks in corporate governance and information disclosure [2][6]. Group 1: Compliance Violations - Shenhuo Co., Ltd was found to have four major compliance violations related to corporate governance and information disclosure [6]. - The company failed to disclose non-operating fund transactions with its controlling shareholder and other related parties as required [7]. - There were significant flaws in handling competition issues, with the company not timely disclosing the competitive relationship with its controlling shareholder [8]. Group 2: Fund Management Issues - Shenhuo Co., Ltd exhibited serious non-compliance in the use and management of raised funds, including the replacement of raised funds with self-raised funds without following necessary procedures [8]. - The company’s decision-making and supervisory mechanisms, referred to as the "three meetings" (shareholders' meeting, board of directors, and supervisory board), were found to be non-compliant, indicating potential weaknesses in governance [8]. Group 3: Accountability of Management - Seven current and former senior executives, including the chairman and general manager, were identified as directly responsible for the violations, highlighting a lack of diligence and accountability [9]. - The Shenzhen Stock Exchange emphasized the need for Shenhuo Co., Ltd and its management to learn from this incident and adhere strictly to relevant laws and regulations regarding information disclosure [9].